Siemens Healthineers Valuation

Is SHL N undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SHL N when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SHL N (MX$968.11) is trading above our estimate of fair value (MX$863.86)

Significantly Below Fair Value: SHL N is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SHL N?

Key metric: As SHL N is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SHL N. This is calculated by dividing SHL N's market cap by their current earnings.
What is SHL N's PE Ratio?
PE Ratio	39.7x
Earnings	€1.52b
Market Cap	€60.25b

SHL N key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.2x
Enterprise Value/EBITDA	20.4x
PEG Ratio	2.2x

Price to Earnings Ratio vs Peers

How does SHL N's PE Ratio compare to its peers?

The above table shows the PE ratio for SHL N vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	32.1x
BDX Becton Dickinson	44.4x	15.6%	US$65.1b
300760 Shenzhen Mindray Bio-Medical Electronics	26.1x	14.7%	CN¥323.7b
RMD ResMed	31.6x	11.1%	US$34.4b
EW Edwards Lifesciences	26.3x	1.9%	US$40.0b
SHL N Siemens Healthineers	39.7x	17.8%	Mex$60.2b

Price-To-Earnings vs Peers: SHL N is good value based on its Price-To-Earnings Ratio (39.7x) compared to the peer average (52.7x).

Price to Earnings Ratio vs Industry

How does SHL N's PE Ratio compare vs other companies in the Global Medical Equipment Industry?

10 Companies	Price / Earnings	Estimated Growth	Market Cap

10 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: SHL N is expensive based on its Price-To-Earnings Ratio (39.7x) compared to the Global Medical Equipment industry average (29.9x).

Price to Earnings Ratio vs Fair Ratio

What is SHL N's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SHL N PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	39.7x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SHL N's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Médica Sur. de

Mex$3.1b

Operates as a healthcare hospital in Mexico.

MEDICA B

Mex$28.84

1.2%

-31.0%

ZimVie

US$186.2m

Develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide.

ZIMV *

US$230.00

n/a

JP¥880.0b

Provides medical-related services primarily to physicians and other healthcare professionals through Internet.

2413 N

JP¥183.50

n/a